B4GALNT1 and neoplasm: Furthermore, the expression of B4GALNT1 (Beta-1,4-N-Acetyl-Galactosaminyltransferase 1) could potentially contribute to the regulation of the tumor micro-environment (TME) and tumor immunity [47].